Literature DB >> 23023956

Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria.

K-C Lim1, P K-H Chow, J C Allen, F J Siddiqui, E S-Y Chan, S-B Tan.   

Abstract

BACKGROUND: Long-term overall survival after liver resection in patients with hepatocellular carcinoma (HCC) within the Milan criteria has been reported to improve in recent years. This study systematically reviewed the outcomes of surgical resection for HCC in patients with good liver function and meeting the Milan criteria for early HCC, published in the past 10 years.
METHODS: A literature search was conducted in PubMed for papers on outcomes of surgical resection for HCC published between January 2000 and December 2010. Cochrane systematic review methodology was used for this review. The primary outcome was overall survival. Secondary outcomes included operative mortality and disease-free survival. Studies that focused on geriatric populations, paediatric populations, a subset of the Milan criteria (such solitary tumours) or included patients with incidental tumours were excluded, as were case reports, conference abstracts, and studies with a large proportion of Child-Pugh grade C liver cirrhosis or unknown Child-Pugh status.
RESULTS: Of 152 studies reviewed, two randomized clinical trials and 27 retrospective case series were eligible for inclusion. The 5-year overall survival rate after resection of HCC ranged from 27 to 81 (median 67) per cent, and the median disease-free survival rate from 21 to 57 (median 37) per cent. There was a trend towards improved overall survival in recent years. The operative mortality rate ranged from 0 to 5 (median 0·7) per cent.
CONCLUSION: Surgical resection offers good overall survival for patients with HCC within the Milan criteria and with good liver function, although recurrence rates remain high. Outcomes have tended to improve in more recent years.
Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23023956     DOI: 10.1002/bjs.8915

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  75 in total

1.  An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.

Authors:  Xiu-Ping Zhang; Kang Wang; Xu-Biao Wei; Le-Qun Li; Hui-Chuan Sun; Tian-Fu Wen; Zong-Tao Chai; Zhen-Hua Chen; Jie Shi; Wei-Xing Guo; Dong Xie; Wen-Ming Cong; Meng-Chao Wu; Wan Yee Lau; Shu-Qun Cheng
Journal:  Oncologist       Date:  2019-05-28

Review 2.  Management of hepatocellular carcinoma.

Authors:  P Fitzmorris; M Shoreibah; B S Anand; A K Singal
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-27       Impact factor: 4.553

3.  Characteristics of Early Recurrence After Curative Liver Resection for Solitary Hepatocellular Carcinoma.

Authors:  Sung-Mi Jung; Jong Man Kim; Gyu-Seong Choi; Choon Hyuck David Kwon; Nam-Joon Yi; Kwang-Woong Lee; Kyung Suk Suh; Jae-Won Joh
Journal:  J Gastrointest Surg       Date:  2018-09-13       Impact factor: 3.452

Review 4.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

Review 5.  Indications, limitations and maneuvers to enable extended hepatectomy: current trends.

Authors:  Dimitrios Dimitroulis; Petros Tsaparas; Serena Valsami; Dimitrios Mantas; Eleftherios Spartalis; Charalampos Markakis; Gregory Kouraklis
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

6.  Hepatic resection associated with good survival for selected patients with multinodular hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Fei-Xiang Wu; Hang Li
Journal:  Tumour Biol       Date:  2014-09-09

7.  Heterogeneity of The CD90+ Population in Different Stages of Hepatocarcinogenesis.

Authors:  Smathorn Thakolwiboon; Jianhui Zhu; Qixing Liang; Theodore H Welling; Min Zhang; David M Lubman
Journal:  J Proteomics Bioinform       Date:  2014-09-12

Review 8.  Advances in managing hepatocellular carcinoma.

Authors:  Marielle Reataza; David K Imagawa
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

9.  The role of liver transplantation or resection for patients with early hepatocellular carcinoma.

Authors:  Kuan-Chun Hsueh; Ting-Ying Lee; Chew-Teng Kor; Tsung-Ming Chen; Tzu-Ming Chang; Shun-Fa Yang; Chung-Bao Hsieh
Journal:  Tumour Biol       Date:  2015-10-22

10.  Aggressive intrahepatic therapies for synchronous hepatocellular carcinoma with pulmonary metastasis.

Authors:  Z Hu; P Huang; Z Zhou; W Li; J Xu; K Xu; J Wang; H Zhang
Journal:  Clin Transl Oncol       Date:  2017-11-06       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.